Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Elantan LA25 capsules
0206010K0BBAEAH
|
Elantan | Isosorbide mononitrate | Cardiovascular System | 26,273 |
|
Elantan LA50 capsules
0206010K0BBADAF
|
Elantan | Isosorbide mononitrate | Cardiovascular System | 13,260 |
|
Elantan 10 tablets
0206010K0BBAAAB
|
Elantan | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Elantan 20 tablets
0206010K0BBABAC
|
Elantan | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Elantan 40 tablets
0206010K0BBACAD
|
Elantan | Isosorbide mononitrate | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.